Base de dados : MEDLINE
Pesquisa : E07.190.250.510 [Categoria DeCS]
Referências encontradas : 8288 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 829 ir para página                         

  1 / 8288 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29424969
[Au] Autor:Martínez-Ramírez EA; Villarreal-Ríos E; Vargas-Daza ER; Galicia-Rodríguez L; Martínez-González L
[Ti] Título:[Cost of family planning care in 10-19 years old teenagers].
[Ti] Título:Costo de atención por servicios de planificación familiar a adolescentes de 10-19 años..
[So] Source:Ginecol Obstet Mex;84(9):551-6, 2016 Sep.
[Is] ISSN:0300-9041
[Cp] País de publicação:Mexico
[La] Idioma:spa
[Ab] Resumo:Objetives: To identify the costs of family planning care in adolescents. Material and methods: Longitudinal study of the cost of care for family planning carried out in 2015 in a group of individuals with age limits of 10 and 19 years in a unit first level of health care in the state of Queretaro, Mexico. The profile of use of family planning (FP) was created for the teen was performed services through counseling, provision of contraception and review of intrauterine device (IUD) in a year; cost projections for the population of adolescents and different coverage scenarios between 5 and 100% were made. Results: The average annual cost was 228.84 Mexican pesos. Ideally the identified cost was 2,708.94 pesos. The projection with 20 % coverage was 207,251,330 pesos. The average annual family planning consultations was 0.9. The most commonly used method was with medroxyprogesterone-estradiol at doses of 25 and 5 mg. Conclusion: The cost of planning in adolescents is low, taking into account the costs that the care of high-risk pregnancies and associated comorbidities.
[Mh] Termos MeSH primário: Anticoncepção/economia
Anticoncepcionais Femininos/economia
Serviços de Planejamento Familiar/economia
Dispositivos Intrauterinos/economia
[Mh] Termos MeSH secundário: Adolescente
Criança
Anticoncepção/métodos
Anticoncepcionais Femininos/administração & dosagem
Combinação de Medicamentos
Estradiol/administração & dosagem
Estradiol/economia
Feminino
Seres Humanos
Estudos Longitudinais
Masculino
Acetato de Medroxiprogesterona/administração & dosagem
Acetato de Medroxiprogesterona/economia
México
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents, Female); 0 (Drug Combinations); 4TI98Z838E (Estradiol); C2QI4IOI2G (Medroxyprogesterone Acetate)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180301
[Lr] Data última revisão:
180301
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180210
[St] Status:MEDLINE


  2 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29172412
[Au] Autor:Antell K; Deshmukh P; Brown EJ
[Ad] Endereço:Christiana Care Family Medicine Residency Program, 1401 Foulk Road, Suite 100 Wilmington, Delaware 19803.
[Ti] Título:Contraception Update: Intrauterine Devices.
[So] Source:FP Essent;462:20-24, 2017 Nov.
[Is] ISSN:2159-3000
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Copper-containing and hormonal intrauterine devices (IUD) are long-acting, highly effective contraceptive methods. They can be used safely by nulliparous patients, adolescents, patients with history of ectopic pregnancy, and patients with risk factors for sexually transmitted infections or a history of pelvic inflammatory disease (PID). These devices can be placed safely immediately postpartum and postabortion and should be inserted when physicians can be reasonably certain that the woman is not pregnant. If a woman with an IUD is shown to be pregnant, the device should be removed if strings are visible. Bleeding and cramping after insertion can be managed with nonsteroidal anti-inflammatory drugs. Perforation is rare, but may require surgical removal of the device. If a woman with an IUD is diagnosed with PID, the device can be left in place and antibiotic treatment initiated.
[Mh] Termos MeSH primário: Serviços de Planejamento Familiar
Medicina de Família e Comunidade
Dispositivos Intrauterinos
[Mh] Termos MeSH secundário: Interações Medicamentosas
Feminino
Seres Humanos
Dispositivos Intrauterinos/efeitos adversos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180227
[Lr] Data última revisão:
180227
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171128
[St] Status:MEDLINE


  3 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28461175
[Au] Autor:Cohen SB; Bouaziz J; Bar-On A; Schiff E; Goldenberg M; Mashiach R
[Ad] Endereço:Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Tel Aviv, Israel; Department of Obstetrics and Gynecology, Herzliya Medical Center, Herzliya, Israel.
[Ti] Título:In-office Hysteroscopic Extraction of Intrauterine Devices in Pregnant Patients Who Underwent Prior Ultrasound-guided Extraction Failure.
[So] Source:J Minim Invasive Gynecol;24(5):833-836, 2017 Jul - Aug.
[Is] ISSN:1553-4669
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:STUDY OBJECTIVE: To determine an effective method of intrauterine device (IUD) retrieval from pregnant women who had previous unsuccessful ultrasound-guided IUD extraction failure. DESIGN: A retrospective cohort study (Canadian task force classification II-1). SETTING: A gynecology department of an outpatient clinic. PATIENTS: Pregnant patients in their first trimester with IUD in situ who underwent prior unsuccessful ultrasound-guided IUD extraction. INTERVENTIONS: Hysteroscopic IUD extraction guided by transabdominal ultrasound. MEASUREMENTS AND MAIN RESULTS: Between 2011 and 2014, 7 of 8 pregnant patients who had undergone previous failed attempts at IUD retrieval via ultrasound guidance underwent successful removal via ultrasound-guided hysteroscopy performed without anesthesia. The sole patient with extraction failure was in her 12th week of pregnancy, and the procedure was concluded to avoid risk to the fetus. Minimal vaginal bleeding was experienced by 2 patients after the procedure. Seven of 8 patients delivered at term without any obstetric complications. One patient had a miscarriage in her 8th week of pregnancy, 2 weeks after successful IUD removal. CONCLUSION: A novel, easy outpatient hysteroscopic technique without anesthesia is presented in case of failure of previous ultrasound-guided IUD removal in early pregnancy. Results are encouraging in this difficult context.
[Mh] Termos MeSH primário: Procedimentos Cirúrgicos Ambulatórios/métodos
Remoção de Dispositivo/métodos
Histeroscopia/métodos
Dispositivos Intrauterinos
Complicações na Gravidez/cirurgia
Reoperação/métodos
Ultrassonografia de Intervenção/métodos
[Mh] Termos MeSH secundário: Aborto Espontâneo/epidemiologia
Aborto Espontâneo/etiologia
Adulto
Procedimentos Cirúrgicos Ambulatórios/efeitos adversos
Eficácia de Contraceptivos
Remoção de Dispositivo/efeitos adversos
Falha de Equipamento
Feminino
Seres Humanos
Histeroscopia/efeitos adversos
Migração de Dispositivo Intrauterino
Gravidez
Primeiro Trimestre da Gravidez
Reoperação/efeitos adversos
Estudos Retrospectivos
Ultrassonografia de Intervenção/efeitos adversos
Ultrassonografia Pré-Natal/métodos
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180223
[Lr] Data última revisão:
180223
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170503
[St] Status:MEDLINE


  4 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29419691
[Au] Autor:Zhou XX; Yu MS; Gu ML; Zhong WX; Wu HR; Ji F; Pan HH
[Ad] Endereço:Department of Gastroenterology.
[Ti] Título:Sigmoid colon translocation of an intrauterine device misdiagnosed as a colonic polyp: A case report.
[So] Source:Medicine (Baltimore);97(6):e9840, 2018 Feb.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: Intrauterine contraceptive devices (IUDs) are recommended as a means of contraception. Translocation of IUD is a rare and serious complication. Colonic inflammatory mass caused by translocated IUD initially misdiagnosed as a colonic polyp is extremely rare and has not been reported yet. PATIENT CONCERNS: This report presents a case of sigmoid colon translocation of intrauterine device on a 37-year-old female patient. Colonoscopy was performed due to her complain of repeated blood in stools and subsequently the patient was misdiagnosed as a sigmoid colon polyp. Nonetheless, the "polyp" was not able to be removed endoscopically. DIAGNOSES: Sigmoid colon translocation of an intrauterine device. INTERVENTIONS: To further clarify the diagnosis, computed tomography (CT) scan was performed and the "polyp" was confirmed to be caused by a translocated IUD. OUTCOMES: The translocated IUD was removed easily by surgery, and the patient recovered soon after the operation. LESSONS: The present case indicates that an annual gynaecologic examination is necessary to determine the position of the IUD, and a CT examination may help confirm an ectopic IUD.
[Mh] Termos MeSH primário: Colite
Colo Sigmoide
Pólipos do Colo/diagnóstico
Colonoscopia/métodos
Erros de Diagnóstico
Migração de Dispositivo Intrauterino/efeitos adversos
[Mh] Termos MeSH secundário: Adulto
Colite/diagnóstico
Colite/etiologia
Colite/cirurgia
Colo Sigmoide/patologia
Colo Sigmoide/cirurgia
Remoção de Dispositivo/métodos
Diagnóstico Diferencial
Feminino
Seres Humanos
Dispositivos Intrauterinos/efeitos adversos
Tomografia Computadorizada por Raios X/métodos
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180209
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009840


  5 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29369858
[Au] Autor:Zolot J
[Ad] Endereço:Joan Zolot, PA.
[Ti] Título:Updated Recommendations for Women's Health.
[So] Source:Am J Nurs;118(2):13, 2018 02.
[Is] ISSN:1538-7488
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:ACOG addresses important issues in contraception and cesarean delivery.
[Mh] Termos MeSH primário: Saúde da Mulher
[Mh] Termos MeSH secundário: Anticoncepcionais Femininos
Disbiose/terapia
Feminino
Seres Humanos
Recém-Nascido
Dispositivos Intrauterinos
Guias de Prática Clínica como Assunto
Gravidez
Vagina/microbiologia
Nascimento Vaginal Após Cesárea
[Pt] Tipo de publicação:NEWS
[Nm] Nome de substância:
0 (Contraceptive Agents, Female)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180208
[Lr] Data última revisão:
180208
[Sb] Subgrupo de revista:AIM; IM; N
[Da] Data de entrada para processamento:180126
[St] Status:MEDLINE
[do] DOI:10.1097/01.NAJ.0000530230.38156.fa


  6 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
[PMID]:29178172
[Au] Autor:Bosteels J; Weyers S; D'Hooghe TM; Torrance H; Broekmans FJ; Chua SJ; Mol BWJ
[Ad] Endereço:Academic Centre for General Practice, Cochrane Belgium, Kapucijnenvoer 33, blok J bus 7001, Leuven, Belgium, 3000.
[Ti] Título:Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility.
[So] Source:Cochrane Database Syst Rev;11:CD011110, 2017 11 27.
[Is] ISSN:1469-493X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Observational evidence suggests a potential benefit with several anti-adhesion therapies in women undergoing operative hysteroscopy (e.g. insertion of an intrauterine device or balloon, hormonal treatment, barrier gels or human amniotic membrane grafting) for decreasing intrauterine adhesions (IUAs). OBJECTIVES: To assess the effectiveness of anti-adhesion therapies versus placebo, no treatment or any other anti-adhesion therapy, following operative hysteroscopy for treatment of female subfertility. SEARCH METHODS: We searched the following databases from inception to June 2017: the Cochrane Gynaecology and Fertility Group Specialised Register; the Cochrane Central Register of Studies (CRSO); MEDLINE; Embase; CINAHL and other electronic sources of trials, including trial registers, sources of unpublished literature and reference lists. We handsearched the Journal of Minimally Invasive Gynecology, and we contacted experts in the field. We also searched reference lists of appropriate papers. SELECTION CRITERIA: Randomised controlled trials (RCTs) of anti-adhesion therapies versus placebo, no treatment or any other anti-adhesion therapy following operative hysteroscopy in subfertile women. The primary outcome was live birth. Secondary outcomes were clinical pregnancy, miscarriage and IUAs present at second-look hysteroscopy, along with mean adhesion scores and severity of IUAs. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies, assessed risk of bias, extracted data and evaluated quality of evidence using the GRADE method. MAIN RESULTS: The overall quality of the evidence was low to very low. The main limitations were serious risk of bias related to blinding of participants and personnel, indirectness and imprecision. We identified 16 RCTs comparing a device versus no treatment (two studies; 90 women), hormonal treatment versus no treatment or placebo (two studies; 136 women), device combined with hormonal treatment versus no treatment (one study; 20 women), barrier gel versus no treatment (five studies; 464 women), device with graft versus device without graft (three studies; 190 women), one type of device versus another device (one study; 201 women), gel combined with hormonal treatment and antibiotics versus hormonal treatment with antibiotics (one study; 52 women) and device combined with gel versus device (one study; 120 women). The total number of participants was 1273, but data on 1133 women were available for analysis. Only two of 16 studies included 100% infertile women; in all other studies, the proportion was variable or unknown.No study reported live birth, but some (five studies) reported outcomes that were used as surrogate outcomes for live birth (term delivery or ongoing pregnancy). Anti-adhesion therapy versus placebo or no treatment following operative hysteroscopy.There was insufficient evidence to determine whether there was a difference between the use of a device or hormonal treatment compared to no treatment or placebo with respect to term delivery or ongoing pregnancy rates (odds ratio (OR) 0.94, 95% confidence interval (CI) 0.42 to 2.12; 107 women; 2 studies; I² = 0%; very-low-quality evidence).There were fewer IUAs at second-look hysteroscopy using a device with or without hormonal treatment or hormonal treatment or barrier gels compared with no treatment or placebo (OR 0.35, 95% CI 0.21 to 0.60; 560 women; 8 studies; I² = 0%; low-quality evidence). The number needed to treat for an additional beneficial outcome (NNTB) was 9 (95% CI 5 to 17). Comparisons of different anti-adhesion therapies following operative hysteroscopyIt was unclear whether there was a difference between the use of a device combined with graft versus device only for the outcome of ongoing pregnancy (OR 1.48, 95% CI 0.57 to 3.83; 180 women; 3 studies; I² = 0%; low-quality evidence). There were fewer IUAs at second-look hysteroscopy using a device with or without graft/gel or gel combined with hormonal treatment and antibiotics compared with using a device only or hormonal treatment combined with antibiotics, but the findings of this meta-analysis were affected by evidence quality (OR 0.55, 95% CI 0.36 to 0.83; 451 women; 5 studies; I² = 0%; low-quality evidence). AUTHORS' CONCLUSIONS: Implications for clinical practiceThe quality of the evidence ranged from very low to low. The effectiveness of anti-adhesion treatment for improving key reproductive outcomes or for decreasing IUAs following operative hysteroscopy in subfertile women remains uncertain. Implications for researchMore research is needed to assess the comparative safety and (cost-)effectiveness of different anti-adhesion treatments compared to no treatment or other interventions for improving key reproductive outcomes in subfertile women.
[Mh] Termos MeSH primário: Histeroscopia/efeitos adversos
Infertilidade Feminina/cirurgia
Doenças Uterinas/terapia
[Mh] Termos MeSH secundário: Âmnio/transplante
Estrogênios/uso terapêutico
Feminino
Géis/uso terapêutico
Seres Humanos
Dispositivos Intrauterinos
Nascimento Vivo/epidemiologia
Gravidez
Ensaios Clínicos Controlados Aleatórios como Assunto
Cirurgia de Second-Look/estatística & dados numéricos
Aderências Teciduais/epidemiologia
Aderências Teciduais/etiologia
Aderências Teciduais/terapia
Doenças Uterinas/epidemiologia
Doenças Uterinas/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Nm] Nome de substância:
0 (Estrogens); 0 (Gels)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180111
[Lr] Data última revisão:
180111
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171128
[St] Status:MEDLINE
[do] DOI:10.1002/14651858.CD011110.pub3


  7 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27773713
[Au] Autor:Karpilow QC; Thomas AT
[Ad] Endereço:Child Trends, Bethesda, MD.
[Ti] Título:Reassessing the importance of long-acting contraception.
[So] Source:Am J Obstet Gynecol;216(2):148.e1-148.e14, 2017 Feb.
[Is] ISSN:1097-6868
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Several recent studies have highlighted the need for greater use of long-acting contraception. The most influential of these studies is the Contraceptive CHOICE Project, which was credited with substantially reducing participants' pregnancy risk by increasing their use of long-acting methods such as intrauterine devices and subdermal implants. However, because participants' rates of nonuse and condom use fell to zero at the outset of the intervention, it is possible that sizable pregnancy reductions could still have been achieved if enrollees had chosen shorter-acting, female-controlled methods such as oral contraception. OBJECTIVE: The objective of the study was to estimate the proportion of the CHOICE Project's fertility impacts that could have been achieved without any increase in long-acting method use. STUDY DESIGN: The FamilyScape 3.0 microsimulation model was used to estimate CHOICE's impact on pregnancy risk and to simulate the counterfactual effect of moving all nonusers and condom users onto shorter-acting, female-controlled methods. FamilyScape models the sexual and contraceptive behaviors of women in the United States between 2006 and 2010, which is the period when CHOICE was implemented. RESULTS: Nearly three quarters of the CHOICE intervention's effects on pregnancy risk could have been achieved if participants had chosen shorter-acting, female-controlled methods over long-acting methods. CONCLUSION: Prioritizing the adoption of long-acting contraception may not be the most advisable strategy for reducing unintended pregnancy. The most impactful interventions will likely be those that increase the use of female-controlled methods, long-acting or otherwise.
[Mh] Termos MeSH primário: Comportamento Contraceptivo/estatística & dados numéricos
Anticoncepção/métodos
Anticoncepcionais Femininos/uso terapêutico
Dispositivos Intrauterinos/utilização
[Mh] Termos MeSH secundário: Simulação por Computador
Anticoncepcionais Orais/uso terapêutico
Preparações de Ação Retardada
Implantes de Medicamento
Feminino
Seres Humanos
Modelos Teóricos
Gravidez
Gravidez não Planejada
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents, Female); 0 (Contraceptives, Oral); 0 (Delayed-Action Preparations); 0 (Drug Implants)
[Em] Mês de entrada:1705
[Cu] Atualização por classe:180112
[Lr] Data última revisão:
180112
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:161107
[St] Status:MEDLINE


  8 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27773708
[Au] Autor:El Ayadi AM; Rocca CH; Kohn JE; Velazquez D; Blum M; Newmann SJ; Harper CC
[Ad] Endereço:Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, United States. Electronic address: alison.elayadi@ucsf.edu.
[Ti] Título:The impact of an IUD and implant intervention on dual method use among young women: Results from a cluster randomized trial.
[So] Source:Prev Med;94:1-6, 2017 Jan.
[Is] ISSN:1096-0260
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Long-acting reversible contraceptives (LARCs) are highly effective at preventing pregnancy but do not protect against sexually transmitted infection (STI). Recent efforts to improve access to intrauterine devices (IUDs) and implants have raised concerns about STI prevention and reduced condom use, particularly among teenagers and young women. We evaluated whether a provider-targeted intervention to increase LARC access negatively impacted dual method use and STI incidence among an at-risk patient population. We conducted a cluster randomized trial in 40 reproductive health centers across the United States from May 2011 to May 2013. After training providers at 20 intervention sites, we recruited 1500 sexually-active women aged 18-25years who did not desire pregnancy and followed them for one year. We assessed intervention effects on dual method use, condom use and STI incidence, modeling dual method use with generalized estimating equations and STI incidence with Cox proportional hazard regression models, accounting for clustering. We found no differences between intervention and control groups in dual method use (14.3% vs. 14.4%, aOR 1.03, 95% CI 0.74-1.44) or condom use (30% vs. 31%, aOR 1.03, 95% CI 0.79-1.35) at last sex at one year. STI incidence was 16.5 per 100 person-years and did not differ between intervention and control groups (aHR 1.20, 95% CI 0.88-1.64). A provider training intervention to increase LARC access neither compromised condom use nor increased STI incidence among young women. Dual method use was very low overall, highlighting the need to bolster STI prevention efforts among adolescents and young women.
[Mh] Termos MeSH primário: Preservativos/utilização
Anticoncepção/métodos
Dispositivos Intrauterinos/utilização
Doenças Sexualmente Transmissíveis/prevenção & controle
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Gravidez
Gravidez não Planejada
Sexo Seguro
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171128
[Lr] Data última revisão:
171128
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE


  9 / 8288 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29064972
[Au] Autor:Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group
[Ti] Título:Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
[So] Source:Obstet Gynecol;130(5):e251-e269, 2017 11.
[Is] ISSN:1873-233X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use. In addition, after the device is removed, the return of fertility is rapid (1, 2). The purpose of this Practice Bulletin is to provide information for appropriate patient selection and evidence-based recommendations for LARC initiation and management. The management of clinical challenges associated with LARC use is beyond the scope of this document and is addressed in Committee Opinion No. 672, Clinical Challenges of Long-Acting Reversible Contraceptive Methods (3).
[Mh] Termos MeSH primário: Anticoncepcionais Femininos/administração & dosagem
Implantes de Medicamento
Dispositivos Intrauterinos
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; PRACTICE GUIDELINE
[Nm] Nome de substância:
0 (Contraceptive Agents, Female); 0 (Drug Implants)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171101
[Lr] Data última revisão:
171101
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171025
[St] Status:MEDLINE
[do] DOI:10.1097/AOG.0000000000002400


  10 / 8288 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29064966
[Ti] Título:Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
[So] Source:Obstet Gynecol;130(5):1173-1175, 2017 Nov.
[Is] ISSN:1873-233X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use. In addition, after the device is removed, the return of fertility is rapid (1, 2). The purpose of this Practice Bulletin is to provide information for appropriate patient selection and evidence-based recommendations for LARC initiation and management. The management of clinical challenges associated with LARC use is beyond the scope of this document and is addressed in Committee Opinion No. 672, Clinical Challenges of Long-Acting Reversible Contraceptive Methods (3).
[Mh] Termos MeSH primário: Anticoncepcionais Femininos
Implantes de Medicamento
Dispositivos Intrauterinos
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; PRACTICE GUIDELINE
[Nm] Nome de substância:
0 (Contraceptive Agents, Female); 0 (Drug Implants)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171101
[Lr] Data última revisão:
171101
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171025
[St] Status:MEDLINE
[do] DOI:10.1097/AOG.0000000000002394



página 1 de 829 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde